Case number 2016-2325
Takeda Pharmaceutical Company v. Sun Pharma Global FZE > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | TAKEDA PHARMACEUTICAL COMPANY v. SUN PHARMA GLOBAL FZE [RULE 36 JUDGMENT] [nonprecedential] (0) |
| May 18, 2017 | 56 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by Clerk of Court. [432472] [SJ] [Entered: 05/18/2017 09:45 AM] (1) |
| Apr 10, 2017 | 55 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Prost,Chief Judge; Newman,Circuit Judge and Dyk,Circuit Judge). [422635] [MJL] [Entered: 04/10/2017 09:20 AM] (5) |
| Apr 5, 2017 | 54 | Submitted after ORAL ARGUMENT by Arlene L. Chow for Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc. and Mark David Schuman for Sun Pharmaceutical Industries, Ltd. and Sun Pharma Global FZE. Panel: Judge: Prost , Judge: Newman , Judge: Dyk. [421613] [JAB] [Entered: 04/05/2017 11:10 AM] (0) |
| Mar 15, 2017 | 53 | Response to oral argument order from the Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. designating Arlene L. Chow as arguing attorney. Designated time for argument: 11 minutes. Designated time for rebuttal: 4 minutes. Service of other counsel by Notice of Docket Activity from this entry. [415953] [Arlene Chow] [Entered: 03/15/2017 10:32 PM] (0) |
| Mar 15, 2017 | 52 | Response to oral argument order from the Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. designating Mark D. Schuman as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [415745] [Mark Schuman] [Entered: 03/15/2017 02:57 PM] (0) |
| Feb 21, 2017 | 51 | NOTICE OF CALENDARING. Panel: 1704I. Case scheduled Apr 05, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 03/15/2017. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [409100] [JAB] [Entered: 02/21/2017 12:17 PM] (0) |
| Dec 14, 2016 | 50 | Notice from Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. regarding conflicts with oral argument (February 8-13, 2017). Service: 12/14/2016 by email. [391013] [Mark Schuman] [Entered: 12/14/2016 02:55 PM] (2) |
| Dec 13, 2016 | 49 | Notice from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. regarding conflicts with oral argument (February 6-8, 2017; March 6-13, 2017). Service: 12/13/2016 by email. [390407] [Arlene Chow] [Entered: 12/13/2016 10:53 AM] (2) |
| Dec 7, 2016 | 48 | 6 paper copies of the Confidential Joint Appendix [45] received from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [389100] [KW] [Entered: 12/07/2016 02:40 PM] (0) |
| Dec 6, 2016 | 47 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [FEB, MAR, APR], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 12/13/2016. [388423] [MJL] [Entered: 12/06/2016 09:05 AM] (0) |
| Dec 5, 2016 | 46 | APPENDIX FILED for Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [41]. Number of Pages: 413. Service: 12/05/2016 by email. Paper copies should be provided of the confidential version only. [388422] [MJL] [Entered: 12/06/2016 09:04 AM] (413) |
| Dec 5, 2016 | 45 | CONFIDENTIAL JOINT APPENDIX FILED for Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [40]. Number of Pages: 430. Service: 12/05/2016 by email. The paper copies of the confidential version of the appendix should be received by the court on or before 12/12/2016. [388420] [MJL] [Entered: 12/06/2016 09:03 AM] (0) |
| Dec 5, 2016 | 44 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 12/05/2016 by email. [388380] [Arlene Chow] [Entered: 12/05/2016 05:48 PM] (4) |
| Dec 5, 2016 | 43 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 12/05/2016 by email. [388379] [Arlene Chow] [Entered: 12/05/2016 05:45 PM] (4) |
| Dec 5, 2016 | 42 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 12/05/2016 by email. [388375] [Arlene Chow] [Entered: 12/05/2016 05:41 PM] (4) |
| Dec 5, 2016 | 41 | TENDERED from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Title: JOINT APPENDIX. Service: 12/05/2016 by email. [388360] [Arlene Chow] [Entered: 12/05/2016 05:08 PM] (413) |
| Dec 5, 2016 | 40 | TENDERED from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 12/05/2016 by email. [388358] [Arlene Chow] [Entered: 12/05/2016 05:04 PM] (0) |
| Nov 23, 2016 | 39 | 6 paper copies of the Confidential Reply Brief [37] received from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [385755] [JCP] [Entered: 11/23/2016 10:22 AM] (0) |
| Nov 21, 2016 | 38 | REPLY BRIEF FILED for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., and Takeda Pharmaceuticals U.S.A., Inc. [36]. Number of Pages: 29. Service: 11/21/2016 by email. Paper copies should be provided of the confidential version only. [385483] [MJL] [Entered: 11/22/2016 01:35 PM] (38) |
| Nov 21, 2016 | 37 | CONFIDENTIAL REPLY BRIEF FILED for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., and Takeda Pharmaceuticals U.S.A., Inc. [35]. Number of Pages: 29. Service: 11/21/2016 by email. The paper copies of the confidential version of the brief should be received by the court on or before 11/28/2016. [385482] [MJL] [Entered: 11/22/2016 01:33 PM] (0) |
| Nov 21, 2016 | 36 | TENDERED from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Title: REPLY BRIEF. Service: 11/21/2016 by email. [385153] [Arlene Chow] [Entered: 11/21/2016 03:58 PM] (38) |
| Nov 21, 2016 | 35 | TENDERED from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Title: CONFIDENTIAL REPLY BRIEF Service: 11/21/2016 by email. [385150] [Arlene Chow] [Entered: 11/21/2016 03:57 PM] (0) |
| Nov 8, 2016 | 34 | ORDER filed. The motion [33] is granted. The joint appendix, their joint statement of compliance with Federal Circuit Rule 33, and their certificates of compliance with Federal Circuit Rule 11(d) are due December 5, 2016. Service: 11/08/2016 by clerk. [381396] [LMS] [Entered: 11/08/2016 03:51 PM] (2) |
| Nov 4, 2016 | 33 | MOTION of Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. to extend the time to 12/05/2016 to file the appendix. Any response is due within 10 days of service, to extend time until 12/05/2016 to file (Joint Statement of Compliance with Rule 33 and Certificates of Compliance with Rule 11(d).). Response/Opposition is due 11/17/2016 [Consent: unopposed]. Service: 11/04/2016 by email. [380375] [Mark Schuman] [Entered: 11/04/2016 10:29 AM] (8) |
| Nov 3, 2016 | 32 | 6 paper copies of the Corrected Confidential Response Brief [29] received from Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. [380132] [KW] [Entered: 11/03/2016 02:36 PM] (0) |
| Nov 1, 2016 | 31 | **TEXT ONLY** ORDER granting motion to extend time to file the reply brief [26] filed by Appellants Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc.. The reply brief is due 11/21/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [379112] [MJL] [Entered: 11/01/2016 08:57 AM] (0) |
| Oct 31, 2016 | 28 | TENDERED from Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Title: CORRECTED RESPONSE BRIEF. Service: 10/31/2016 by email. [378946] [Mark Schuman] [Entered: 10/31/2016 03:33 PM] (63) |
| Oct 31, 2016 | 29 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. [27]. Number of Pages: 53. Service: 10/31/2016 by email. The paper copies of the confidential version of the brief should be received by the court on or before 11/07/2016. [379104] [MJL] [Entered: 11/01/2016 08:53 AM] (0) |
| Oct 31, 2016 | 30 | CORRECTED BRIEF FILED for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. [28]. Number of Pages: 53. Service: 10/31/2016 by email. Paper copies should be provided of the confidential version only. [379107] [MJL] [Entered: 11/01/2016 08:55 AM] (63) |
| Oct 31, 2016 | 27 | TENDERED from Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Title: CORRECTED CONFIDENTIAL RESPONSE BRIEF Service: 10/31/2016 by email. [378940] [Mark Schuman] [Entered: 10/31/2016 03:31 PM] (0) |
| Oct 31, 2016 | 26 | MOTION of Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. to extend the time to 11/21/2016 at 11:59 pm to file the reply brief. Response/Opposition is due 11/10/2016 [Consent: unopposed]. Service: 10/31/2016 by email. [378879] [Arlene Chow] [Entered: 10/31/2016 02:44 PM] (6) |
| Oct 25, 2016 | 25 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: Notice regarding the ECF account of Mr. Eric J. Lobenfeld for Takeda Pharmaceuticals America, Inc., Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals U.S.A., Inc.. The e-mail address, (nicole.nussbaum@hoganlovells.com), associated with your CM/ECF account has generated a delivery failure notice. Counsel should promptly report a change in contact information with the Pacer Service Center (see Fed. Cir. R. 47.3(c)(1). [377330] [PMM] [Entered: 10/25/2016 09:46 AM] (0) |
| Oct 25, 2016 | 24 | NOTICE OF REJECTION: The Brief of Appellees (Confidential [22], Non-Confidential [23]) is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 11/08/2016.. Appellants' reply brief is due 11/07/2016. Service as of this date by Clerk of Court. [377322] [MJL] [Entered: 10/25/2016 09:33 AM] (2) |
| Oct 24, 2016 | 23 | TENDERED from Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Title: RESPONSE BRIEF. Service: 10/24/2016 by email. [377203]. This brief has been rejected. See Doc. No. [24]. [Mark Schuman] [Entered: 10/24/2016 04:01 PM] (0) |
| Oct 24, 2016 | 22 | TENDERED from Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 10/24/2016 by email. [377199]. This brief has been rejected. See Doc. No. [24]. [Mark Schuman] [Entered: 10/24/2016 03:59 PM] (0) |
| Sep 16, 2016 | 21 | 6 paper copies of the Corrected Opening Brief [18] received from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [366959] [JCP] [Entered: 09/16/2016 11:46 AM] (0) |
| Sep 15, 2016 | 20 | Entry of appearance for Caroline L. Marsili as of counsel for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 09/15/2016 by email. [366722] [Mark Schuman] [Entered: 09/15/2016 03:01 PM] (2) |
| Sep 15, 2016 | 19 | Entry of appearance for Jonathan D. Carpenter as of counsel for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 09/15/2016 by email. [366718] [Mark Schuman] [Entered: 09/15/2016 02:59 PM] (2) |
| Sep 14, 2016 | 18 | CORRECTED BRIEF FILED for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [17]. Number of Pages: 34. Service: 09/14/2016 by email. The paper copies of the brief should be received by the court on or before 09/19/2016. [366419] [MJL] [Entered: 09/14/2016 02:36 PM] (90) |
| Sep 14, 2016 | 17 | TENDERED from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Title: CORRECTED OPENING BRIEF. Service: 09/14/2016 by email. [366390] [Arlene Chow] [Entered: 09/14/2016 01:38 PM] (90) |
| Sep 14, 2016 | 16 | NOTICE OF REJECTION: The Opening Brief for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc. [14] is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 09/28/2016. Brief for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd. is due 10/24/2016. Service as of this date by Clerk of Court. [366306] [MJL] [Entered: 09/14/2016 11:03 AM] (2) |
| Sep 13, 2016 | 15 | Entry of appearance for Thomas P. Schmidt as of counsel for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 09/13/2016 by email. [365971] [Thomas Schmidt] [Entered: 09/13/2016 07:23 AM] (1) |
| Sep 12, 2016 | 14 | TENDERED from Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Title: OPENING BRIEF. Service: 09/12/2016 by email. [365927]. This brief has been rejected. See Doc. No. [16]. [Arlene Chow] [Entered: 09/12/2016 05:28 PM] (0) |
| Jul 26, 2016 | 13 | Corrected Entry of appearance for Eric J. Lobenfeld as of counsel for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 07/26/2016 by email. [353759] [Eric Lobenfeld] [Entered: 07/26/2016 03:30 PM] (3) |
| Jul 26, 2016 | 12 | Certificate of Interest for the Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 07/26/2016 by email. [353738] [Arlene Chow] [Entered: 07/26/2016 02:49 PM] (3) |
| Jul 26, 2016 | 11 | Docketing Statement for the Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 07/26/2016 by email. [353736] [Arlene Chow] [Entered: 07/26/2016 02:46 PM] (4) |
| Jul 26, 2016 | 10 | Entry of appearance for Arlene L. Chow as principal counsel for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 07/26/2016 by email. [353733] [Arlene Chow] [Entered: 07/26/2016 02:43 PM] (3) |
| Jul 26, 2016 | 9 | Entry of appearance for Eric J. Lobenfeld as of counsel for Appellants Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc. and Takeda Pharmaceuticals U.S.A., Inc.. Service: 07/26/2016 by email. [353725] [Eric Lobenfeld] [Entered: 07/26/2016 02:31 PM] (3) |
| Jul 22, 2016 | 8 | Corrected Certificate of Interest for the Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 07/22/2016 by email. [353031] [Mark Schuman] [Entered: 07/22/2016 02:58 PM] (3) |
| Jul 22, 2016 | 7 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The docketing statement [5] filed by Appellees was not text-searchable. CORRECTION: For future filings, please ensure the entire document is text-searchable. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [352828] [MJL] [Entered: 07/22/2016 09:25 AM] (0) |
| Jul 22, 2016 | 6 | NOTICE OF DEFICIENCY: The certificate of interest [4] filed by Appellees Sun Pharmaceutical Industries, Ltd. and Sun Pharma Global FZE in 16-2325 is incomplete and therefore cannot be accepted for filing at this time. Item #2 was left blank, as was item #3 with respect to Sun Pharmaceutical Industries, Ltd.. You are being afforded the opportunity to correct the deficiency. Please ensure all items are filled out for all parties. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [352823] [MJL] [Entered: 07/22/2016 09:21 AM] (0) |
| Jul 21, 2016 | 5 | Docketing Statement for the Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 07/21/2016 by email. [352753] [Mark Schuman] [Entered: 07/21/2016 04:42 PM] (4) |
| Jul 21, 2016 | 4 | Certificate of Interest for the Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 07/21/2016 by email. [352750] [Mark Schuman] [Entered: 07/21/2016 04:41 PM] (0) |
| Jul 21, 2016 | 3 | Entry of appearance for Samuel T. Lockner as of counsel for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 07/21/2016 by email. [352749] [Mark Schuman] [Entered: 07/21/2016 04:39 PM] (2) |
| Jul 21, 2016 | 2 | Entry of appearance for Mark D. Schuman as principal counsel for Appellees Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.. Service: 07/21/2016 by email. [352748] [Mark Schuman] [Entered: 07/21/2016 04:37 PM] (2) |
| Jul 12, 2016 | 1 | Appeal docketed. Received: 07/12/2016. [350142]Entry of Appearance due 07/26/2016. Certificate of Interest is due on 07/26/2016. Docketing Statement due 07/26/2016. Appellant/Petitioner's brief is due 09/12/2016. [MJL] [Entered: 07/12/2016 12:17 PM] (46) |
